Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.49
+1.93 (0.93%)
AAPL  273.37
+1.23 (0.45%)
AMD  210.99
-2.85 (-1.33%)
BAC  50.81
+0.40 (0.79%)
GOOG  312.75
+1.83 (0.59%)
META  648.12
+8.82 (1.38%)
MSFT  394.22
+5.22 (1.34%)
NVDA  194.73
+1.88 (0.97%)
ORCL  149.25
+3.11 (2.13%)
TSLA  417.53
+8.15 (1.99%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.